Actively Recruiting

Phase 3
Age: 0Days - 28Days
All Genders
NCT05907317

Safeguarding the Brain of Our Smallest Children-IIIv (SafeBoosC-IIIv)

Led by Copenhagen Trial Unit, Center for Clinical Intervention Research · Updated on 2025-04-25

1610

Participants Needed

1

Research Sites

198 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The objective of the SafeBoosC-IIIv trial is to assess benefits and harms of cerebral oximetry in newborns receiving invasive mechanical ventilation. The hypothesis is that: i. Cerebral oximetry added to usual care versus usual care alone in newborns receiving invasive mechanical ventilation will increase the number of hospital-free days within 90 days of randomisation. ii. The intervention will decrease a composite outcome of death or moderate to severe neurodevelopmental disability and/or increase the mean PARCA-R non-verbal cognitive score at two years of corrected age.

CONDITIONS

Official Title

Safeguarding the Brain of Our Smallest Children-IIIv (SafeBoosC-IIIv)

Who Can Participate

Age: 0Days - 28Days
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Gestational age more than or equal to 28+0
  • Postnatal age less than 28 days
  • Expected to receive invasive mechanical ventilation for at least 24 hours as judged by the physician
  • Parental informed consent obtained unless opt-out or deferred consent is used
  • Availability of a cerebral oximeter to start monitoring within six hours after invasive mechanical ventilation begins
Not Eligible

You will not qualify if you...

  • Suspicion or confirmation of brain injury or disorder such as severe hypoxic-ischemic encephalopathy, severe intraventricular haemorrhage, cerebral malformation, genetic or metabolic disease
  • Suspicion or diagnosis of congenital heart malformations likely requiring surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hospital Universitario 12 de Octubre

Madrid, Spain

Actively Recruiting

Loading map...

Research Team

C

Caroline Kamp, PhD

CONTACT

J

Johanne Juul Petersen

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here